Junyuan Jerry Wang

Insider Reports History

Location
New York, NY
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Junyuan Jerry Wang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Class A Common Stock 3,866,228 $11,173,399 $2.89 11 Nov 2024 Direct
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Class A Common Stock 2,246,458 $6,492,264 $2.89 11 Nov 2024 By LLC
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Stock Option (Right to Buy) 388,299 09 Apr 2024 Direct
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Warrants (Right to Buy) 86,471 03 Sep 2024 Direct
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Warrants (Right to Buy) 57,647 03 Sep 2024 By LLC
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Series A Preferred Stock 0 04 Sep 2024 By LLC
Nuvation Bio Inc. CEO, ANHEART THERAPEUTICS LTD., Director Series A Preferred Stock 0 04 Sep 2024 Direct

Insider Reports Filed by Junyuan Jerry Wang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVB Nuvation Bio Inc. 11 Nov 2024 1 -$162,883 4 CEO, ANHEART THERAPEUTICS LTD., Director 13 Nov 2024, 16:28
NUVB Nuvation Bio Inc. 03 Sep 2024 8 $0 4 CEO, ANHEART THERAPEUTICS LTD., Director 05 Sep 2024, 16:46
NUVB Nuvation Bio Inc. 09 Apr 2024 4 $0 4 CEO, ANHEART THERAPEUTICS LTD., Director 11 Apr 2024, 18:30
NUVB Nuvation Bio Inc. 09 Apr 2024 0 $0 3 CEO, ANHEART THERAPEUTICS LTD., Director 11 Apr 2024, 18:29